Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDoğan, Sultan
dc.date.accessioned2022-05-11T14:41:02Z
dc.date.available2022-05-11T14:41:02Z
dc.date.issued2011
dc.identifier.issn2146-1473
dc.identifier.issn2146-2380
dc.identifier.urihttps://doi.org/10.5455/jmood.20110629055304
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9033
dc.description.abstractNormal sexual function is a biopsychosocial process; sexual problems almost always has organic and psychological components and requires multidisciplinary evaluation and treatment. Factors such as relationship conflicts, stresfull events, poor sexual education, aging, declining testosterone levels, medical illness, certain medications, and depressive disorder can contribute to sexual dysfunctions. Depression is one of the most prevalent medical disorders and has been recognised as a distinct pathologic entity from early Egyptian times. The character of depressive symptoms such as depressed mood, diminished interest or pleasure, significant weight loss or gain, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness, diminished ability to think or concentrate; indecisiveness, recurrent thoughts of death, suicidal ideation, suicide attempt, or specific plan for suicide depends to a large extent on the severity of the disorder. Sexual dysfunction is often implicated in depression, but current nosology of sexual dysfunction and depression does not adequately address this relationship. Although decreased sexual desire is most often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile dysfunction in men, and absent or delayed orgasm are also prevalent in depressive individuals. Sexual dysfunction is also a frequent undesirable effect of treatment with antidepressants and is one of the major reasons for early medication discontinuation. Selective serotonin reuptake inhibitors are the most widely prescribed antidepressants and have significant effects on arousal and orgasm compared with antidepressants that target norepinefrine, dopamine, and melatonin system. The aim of this paper was to review the phenomenology of sexual dysfunction and to focus on the clinical assessment and therapeutic interventions used for sexual dysfunction in depressed patients.en_US
dc.language.isoturen_US
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A Sen_US
dc.identifier.doi10.5455/jmood.20110629055304
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSexualityen_US
dc.subjectsexual dysfunctionsen_US
dc.subjectdepressive disorderen_US
dc.subjectantidepressantsen_US
dc.subjectSSRIen_US
dc.titleSexual dysfunctions, depression and antidepressantsen_US
dc.typereviewen_US
dc.relation.ispartofJournal of Mood Disordersen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Ruh Sağlığı ve Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume1en_US
dc.identifier.issue2en_US
dc.identifier.startpage81en_US
dc.identifier.endpage86en_US
dc.institutionauthorDoğan, Sultan
dc.relation.publicationcategoryDiğeren_US
dc.identifier.wosWOS:000218917600007en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster